A wide range of histological subtypes, mainly a luminal hormone receptor positive phenotype, can be seen in breast cancer patients with BRCA2 germline mutation (Dabbs 2012; Lakhani et al. 2012; Lips et al. 2017). This evidence concerns the gene NR4A1 and breast carcinoma.